EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Multi-Transcriptomic Uncovers Actionable Signatures and Drug Repurposing Candidates for ccRCC–Hypertension Comorbidity

Yinnan Zhang, Boon Seng Kho, Xixi Wang, Huanhuan Lu, Miao Zhu, Rentao Zhu, Yinyin Wang iD

Cancers · 14.07.2026 · 18 (14) · 2250

DOI: 10.3390/cancers18142250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 14.07.2026. Verfasst von Yinnan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Scientists Fund of the National Natural Science Foundation of China, Jiangsu Province Science Foundation for Youths, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension is a common comorbidity and risk factor for clear cell renal cell carcinoma (ccRCC), yet the molecular mechanisms linking these two diseases remain unclear. This study aimed to investigate hypertension-related molecular signatures in ccRCC using integrated multi-transcriptomic analyses.

Method

Hypertension-related differentially expressed genes (DEHRGs) in ccRCC were identified by integrating transcriptomic data from the TCGA-KIRC cohort with the GeneCards database. Functional enrichment, WGCNA, machine learning, GSVA, survival analysis, and Mendelian randomization were performed to identify and characterize hub genes. Spatial and single-cell transcriptomic analyses were used to investigate tumor heterogeneity and predict candidate therapeutic compounds, which were subsequently evaluated in vitro.

Results

Four hypertension-related hub genes—SCNN1G, CASR, KCNJ1, and WNK4—were identified and were mainly involved in ion transport, electrolyte homeostasis, and blood pressure regulation. Diagnostic models based on these genes showed good discriminatory performance between tumor and normal tissues, and the nomogram showed good calibration and potential clinical benefit. Higher hypertension-related transcriptional activity was associated with significantly poorer overall survival, while MR analysis suggested a genetic association with ccRCC risk. Spatial transcriptomics revealed pronounced spatial heterogeneity of SCNN1G, CASR, KCNJ1, and WNK4, with these hub genes predominantly enriched in stromal and immune regions. Single-cell-based drug screening identified candidate compounds predicted to have antitumor activity, among which epicatechin gallate (ECG) and pseudoginsenoside-F11 showed favorable tumor selectivity.

Conclusions

This study systematically characterized hypertension-related molecular signatures in ccRCC and identified SCNN1G, CASR, KCNJ1, and WNK4 as key hub genes. These genes may contribute to the molecular association between hypertension and ccRCC. They also represent promising candidate biomarkers and therapeutic targets. Integrated spatial and single-cell analyses further identified pseudoginsenoside-F11 and ECG as potential therapeutic compounds and supporting a potential molecular association between hypertension and ccRCC.

Schlagwörter

Stichwörter der Autor:innen

clear cell renal cell carcinomahypertensionintegrative analysis

Autor:innen und Institutionen

  • Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Rehabilitation Department, Changzhou Children's Hospital, Nantong University, Nantong 213003, China.
  • Department of Hematology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou University, Yangzhou 225001, China.
  • Kunshan Fifth People's Hospital, Suzhou 215341, China.

ORCID-Profile: Yinyin Wang

Förderung

  • Young Scientists Fund of the National Natural Science Foundation of China
  • Jiangsu Province Science Foundation for Youths
  • National Natural Science Foundation of China
  • 2023 Science and Technology Project of Changzhou Health Commission
  • Hospital-Level Project of Changzhou Children's Hospital
  • Hospital-Level Project of Changzhou Children’s Hospital

Zitieren

APA

Zhang, Y., Kho, B. S., Wang, X., Lu, H., Zhu, M., Zhu, R., & Wang, Y. (2026). Integrative Multi-Transcriptomic Uncovers Actionable Signatures and Drug Repurposing Candidates for ccRCC–Hypertension Comorbidity. Cancers, 18(14), 2250. https://doi.org/10.3390/cancers18142250

Vancouver

Zhang Y, Kho BS, Wang X, Lu H, Zhu M, Zhu R, et al. Integrative Multi-Transcriptomic Uncovers Actionable Signatures and Drug Repurposing Candidates for ccRCC–Hypertension Comorbidity. Cancers. 2026;18(14):2250. doi:10.3390/cancers18142250

BibTeX
@article{Zhang2026,
  author = {Zhang, Yinnan and Kho, Boon Seng and Wang, Xixi and Lu, Huanhuan and Zhu, Miao and Zhu, Rentao and Wang, Yinyin},
  title = {Integrative Multi-Transcriptomic Uncovers Actionable Signatures and Drug Repurposing Candidates for ccRCC–Hypertension Comorbidity},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {14},
  pages = {2250},
  doi = {10.3390/cancers18142250}
}
Kostenlos starten →